FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical composition for treatment of oncological diseases based on sodium dichloroacetate, characterised by fact, that it additionally contains theobromine (3,7-dimethylxanthine) or caffeine (1,3,7- threemethylxanthine) or paraxanthine (1,7- dimethylxanthine), with ratio of sodium dichloroacetate to xathine methyl derivative of those mentioned above constitutes 1:1-10:1.
EFFECT: pharmaceutical composition ensures synergetic effect.
9 tbl, 9 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS OF PROSTATE GLANDS | 2015 |
|
RU2589266C1 |
| METHOD FOR PROCESSING TUMOUR CELLS | 2016 |
|
RU2632429C1 |
| PHARMACEUTICAL COMPOSITION FOR ONCOLOGICAL DISEASES | 2011 |
|
RU2463053C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS | 2019 |
|
RU2710273C1 |
| STABLE PHARMACEUTICAL COMPOSITION BASED ON ACTINOMYCIN D FOR INJECTIONS | 2014 |
|
RU2587716C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF AN EXCESSIVE WEIGHT OR OBESITY, METHOD OF IMPROVEMENT OF DOMESTIC ANIMAL CARCASS QUALITY | 1992 |
|
RU2109511C1 |
| AGENT FOR TARGETED THERAPY OF MALIGNANT GROWTHS | 2018 |
|
RU2699558C2 |
| METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 |
|
RU2794315C1 |
| METHOD FOR PREVENTION OF PULMONARY METASTATIC LESIONS EXPERIMENTALLY | 2013 |
|
RU2546034C1 |
| METHOD OF TREATING MELANOMA IN VIVO | 2023 |
|
RU2824428C2 |
